1. Home
  2. SOTK vs RNXT Comparison

SOTK vs RNXT Comparison

Compare SOTK & RNXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sono-Tek Corporation

SOTK

Sono-Tek Corporation

N/A

Current Price

$5.78

Market Cap

72.1M

Sector

Technology

ML Signal

N/A

Logo RenovoRx Inc.

RNXT

RenovoRx Inc.

N/A

Current Price

$1.52

Market Cap

79.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SOTK
RNXT
Founded
1975
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
72.1M
79.4M
IPO Year
1995
2021

Fundamental Metrics

Financial Performance
Metric
SOTK
RNXT
Price
$5.78
$1.52
Analyst Decision
Buy
Strong Buy
Analyst Count
2
4
Target Price
★ $7.50
$7.13
AVG Volume (30 Days)
44.3K
★ 1.1M
Earning Date
10-13-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 37.50
20.00
EPS
★ 0.05
N/A
Revenue
★ $20,909,315.00
$1,123,000.00
Revenue This Year
$3.73
$244.84
Revenue Next Year
$10.38
$195.26
P/E Ratio
$115.80
★ N/A
Revenue Growth
1.97
★ 2511.63
52 Week Low
$3.40
$0.70
52 Week High
$6.24
$2.59

Technical Indicators

Market Signals
Indicator
SOTK
RNXT
Relative Strength Index (RSI) 69.22 47.41
Support Level $4.59 $1.55
Resistance Level $6.24 $1.80
Average True Range (ATR) 0.33 0.12
MACD 0.15 -0.05
Stochastic Oscillator 86.92 22.86

Price Performance

Historical Comparison
SOTK
RNXT

About SOTK Sono-Tek Corporation

Sono-Tek Corp designs and manufactures ultrasonic coating systems for applying precise, thin film coatings to add functional properties, protect or strengthen surfaces on parts and components for the microelectronics/electronics, alternative energy, medical, industrial, and emerging research & development/other markets. The company designs and manufacture custom-engineered ultrasonic coating systems incorporating its patented technology, in combination with applications engineering knowledge, to assist its customers in achieving their desired coating solutions.

About RNXT RenovoRx Inc.

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical needs with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed for targeted therapeutic delivery across the arterial wall near the tumor site (known as intra-arterial, or IA delivery) to bathe the target tumor, while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

Share on Social Networks: